EGM
CSTL icon

Engineers Gate Manager’s Castle Biosciences CSTL Stock Holding History

Engineers Gate Manager’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$703K Buy
29,480
+11,224
+61% +$250K 0.01% 1288
2026
Q1 		$448K Sell
18,256
-4,693
-20% -$154K 0.01% 1471
2025
Q4 		$893K Sell
22,949
-23,557
-51% -$759K 0.01% 1096
2025
Q3 		$1.06M Sell
46,506
-20,746
-31% -$421K 0.01% 1123
2025
Q2 		$1.37M Buy
67,252
+14,329
+27% +$265K 0.02% 947
2025
Q1 		$1.06M Buy
52,923
+34,201
+183% +$847K 0.02% 1026
2024
Q4 		$499K Sell
18,722
-31,360
-63% -$955K 0.01% 1428
2024
Q3 		$1.43M Buy
50,082
+22,710
+83% +$578K 0.03% 805
2024
Q2 		$596K Sell
27,372
-2,624
-9% -$58.5K 0.01% 1143
2024
Q1 		$664K Sell
29,996
-1,271
-4% -$27.7K 0.02% 1047
2023
Q4 		$675K Buy
+31,267
New +$550K 0.02% 1016
2023
Q2 		– Sell
-22,560
Closed -$513K – 1784
2023
Q1 		$513K Sell
22,560
-16,969
-43% -$415K 0.02% 961
2022
Q4 		$931K Buy
39,529
+29,992
+314% +$695K 0.06% 514
2022
Q3 		$249K Sell
9,537
-99,403
-91% -$2.79M 0.02% 1209
2022
Q2 		$2.39M Buy
+108,940
New +$2.53M 0.09% 295

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Engineers Gate Manager's CSTL Position: Q2 2026 in Review

Engineers Gate Manager increased its Castle Biosciences (CSTL) stake by 61% in Q2 2026, buying an estimated $250K and bringing the position to 29,480 shares worth $703K. The position accounts for 0.01% of the portfolio, ranked #1288.

Engineers Gate Manager first reported a position in CSTL in Q2 2022 and has held it in 15 quarters since. The position peaked at $2.39M in Q2 2022. 176 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • Engineers Gate Manager held 29,480 shares of Castle Biosciences worth $703K as of Q2 2026.
  • Engineers Gate Manager bought 11,224 Castle Biosciences shares in Q2 2026, an estimated $250K.
  • Castle Biosciences made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1288 holding.
  • Engineers Gate Manager first reported a position in Castle Biosciences in Q2 2022 and has held it in 15 quarters since.
  • Engineers Gate Manager's Castle Biosciences position peaked at $2.39M in Q2 2022.
  • 176 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.